GLRX5 and flatulence: Considering the prevalence of both PrsA1 and PrsA2 in GAS and the observed cross-reactivity of antibody raised through PrsA1 and PrsA2 immunization, it may be challenging to completely exclude the influence of another PrsA isoform when immunizing animals with only one of the PrsA isoforms.